RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Cost-effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease
Aggarwal, K., Vredenburg, M., Mladsi, D. D., & Barnett, C. (2020). Cost-effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Journal of managed care & specialty pharmacy, 26(4-a Suppl), Article s58. https://doi.org/10.18553/jmcp.2020.26.4-a.s1
The abstracts presented in this program were originally slated to be presented at the AMCP 2020 meeting in Houston, Texas, April 21-24. The meeting was canceled because of the COVID-19 crisis. In lieu of the scheduled poster presentations, many poster presenters have shared additional information about their research at https://plan.core-apps.com/amcp2020. Professional abstracts that have been reviewed are published in the
Journal of Managed Care & Specialty Pharmacy's Meeting Abstracts supplement.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.